Gene Panel Market Trends

Skyquest Technology's expert advisors have carried out comprehensive research on the gene panel market to identify the major global and regional market trends and growth opportunities for leading players and new entrants in this market. The analysis is based on in-depth primary and secondary research to understand the major market drivers and restraints shaping the future development and growth of the industry.

Gene Panel Market Dynamics

Drivers

Advances in Sequencing Technologies

  • The global gene panel market is being driven by innovations of next-generation sequencing (NGS) technologies that offer better precision, increased pace and cost savings for genetic analysis. This has made it possible to have extensive genomic profiling and thus encourage personalization of medicine hence stimulating the demand for gene panels in clinical and research applications.

Rising Demand for Personalized Medicine

  • The reason for this is that more attention is being paid to personalized medicine which is a big factor affecting the global gene panel market. The increasing reliance on gene panels to provide specific diagnostics and targeted therapies is likely to fuel market growth and innovations in genetic testing as healthcare treatment moves towards individual genetic profiles.

Restraints

Limited Awareness and Education

  • The market growth can be hindered by the professionals in healthcare and patients who have limited knowledge and comprehension of gene panel testing. A lack of education on the advantages and applications of DNA panels may lead to a slower uptake and usage, which would affect the genetic testing market expansion and its potential impacts.

Variability in Test Accuracy and Interpretation

  • A challenge may be the variation in the way gene panels are interpreted, including their accuracy. Clinical diagnostic based on gene panels might not be so popular due to clinical uncertainty and loss of trust resulting from variability in test results and difficulties instructional analysis of complex genetic data.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Gene Panel Market size was valued at USD 2.86 Billion in 2023 and is poised to grow from USD 3.41 Billion in 2024 to USD 14.02 Billion by 2032, growing at a CAGR of 19.30% during the forecast period (2025-2032).

Global gene panel market is competitive with key players who drive innovations and expand markets. To keep up with the high demand for personalized medicine, rapid technological advancements have continued fueling competition among these companies that specialize in gene panels like Illumina, Thermo Fisher Scientific or Agilent Technologies and offer advanced sequencing technologies in addition to complete solutions for gene panels. Fast technology progressions and a growing desire for individualized treatment are spurring on going innovations as well as frequent expansion in the market. 'Qiagen  ', 'Roche  ', 'Illumina  ', 'Thermo Fisher Scientific  ', 'Agilent Technologies  ', 'Bio-Rad Laboratories  ', 'PerkinElmer  ', 'Becton, Dickinson and Company (BD)  ', 'Sangamo Therapeutics  ', 'Genomics England ', 'Personalis, Inc.  ', 'Twist Bioscience Corporation ', 'Castle Biosciences, Inc ', 'Neogenomics Laboratories  ', 'NantHealth  ', 'Macrogen  ', 'Myrtelle Inc.  ', 'Eurofins Genomics ', 'Guardant Health, Inc. ', 'Myriad Genetic Laboratories Inc.'

The global gene panel market is being driven by innovations of next-generation sequencing (NGS) technologies that offer better precision, increased pace and cost savings for genetic analysis. This has made it possible to have extensive genomic profiling and thus encourage personalization of medicine hence stimulating the demand for gene panels in clinical and research applications.

Surge in Personalized Medicine Adoption: Personalized medicine is on the rise in the global gene panel market as healthcare practitioners are using gene panels more frequently for customized treatment approaches. Such a trend that has been fueled by advancements in genomics has enabled better diagnostics and focused therapies that can improve patients’ health outcomes thus boosting demand for these products.

North America dominates the global gene panel market due to its advanced healthcare infrastructure, high investment in biotechnology research, and a strong focus on personalized medicine. Through the allocation of massive funds for genomic research within this region, one can observe that there are strong regulatory structures already in place as well as a high uptake of advanced technologies. Demand for complex gene panels in the US and Canadian regions is primarily driven by major pharmaceutical and biotechnology firms which have a solid network of hospitals and diagnostic laboratories. Other than that, the gene panel industry continues to grow due to North America’s conducive policy environment and collaboration among researchers thereby fostering innovation.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Gene Panel Market
Gene Panel Market

Report ID: SQMIG35H2314

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE